Kestra Medical Technologies Reports Strong Q4 Revenue Growth and Provides Fiscal 2027 Guidance

Kestra Medical Technologies (NASDAQ: KMTS) reported fourth-quarter revenue of $28.6 million, a 66% increase year-over-year, driven by strong demand for its ASSURE wearable cardioverter defibrillator system. The company also raised fiscal 2027 guidance to $137 million in revenue and highlighted margin improvements due to scaling the rental model.

By MarketBeat Wed, July 15, 2026 at 1:02 AM GMT+3 8 min read · Yahoo Finance · July 14, 2026, 22:02 UTC

Tickers: $KMTS

Topics: gross_margin_expansion medical_devices revenue_growth

Read the full article at Yahoo Finance

More World news

Nvidia CEO Jensen Huang Resigns Amid Allegations of Personal Misconduct and China Export Control Concerns The Verge · November 12, 2026, 17:44 UTC
NYSE Sees $500 Billion in Market Cap Transfers from Competitors in 2026 PR Newswire · November 12, 2026, 17:45 UTC
Hyperion DeFi Reports Record Net Income and Positive Operating Cash Flow in Q3 2026 Motley Fool · November 12, 2026, 17:40 UTC
Suburban Propane Reports Fiscal 2026 Results with Increased Adjusted EBITDA and RNG Growth Motley Fool · November 12, 2026, 17:40 UTC
Altimmune Reports Third Quarter 2026 Financial Results Amid Increased R&D Spending Motley Fool · November 12, 2026, 17:40 UTC
CorMedix Reports Q3 2026 Results Amid DefenCath Pricing Transition and Heron Therapeutics Acquisition Plans Motley Fool · November 12, 2026, 17:40 UTC
NUGL Reports Third Quarter Net Income of $0.19 Million and Revenue of $1.04 Million Seeking Alpha · November 12, 2026, 17:38 UTC
Allstate Announces Quarterly Dividend of $1.08 Per Share PR Newswire · November 12, 2026, 17:38 UTC
Stephanie Link Shifts AI Allocation from Nvidia to Micron Technology Following CEO Resignation CNBC · November 12, 2026, 17:37 UTC
Boyd Group Reports 28% Revenue Growth and $90 Million in Cost Savings for Q3 2026 Motley Fool · November 12, 2026, 17:33 UTC